AU Patent

AU2022275529A1 — Granulate formulation of 5-methyl-1-phenyl-2(1H)-pyridone and method of making the same

Assigned to F Hoffmann La Roche AG · Expires 2023-01-19 · 3y expired

What this patent protects

DCC-25/11/2022 ABSTRACT The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.

USPTO Abstract

DCC-25/11/2022 ABSTRACT The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.

Drugs covered by this patent

Patent Metadata

Patent number: AU2022275529A1
Jurisdiction: AU
Classification: —
Expires: 2023-01-19
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.